SARS CoV 2 News and Research

RSS

Post-COVID condition largely due to SARS-CoV 2 infection, in addition to the indirect pandemic effects

A study conducted by the Geneva University Hospitals and the University of Geneva addresses a main question that physicians and SARS-CoV-2 experts have been asking since the emergence of post-COVID condition (also called Long COVID): is it due to the infection itself or to indirect effects of the pandemic situation and the sanitary measures?

16 Mar 2022

Tracking the mutating coronavirus variants

Viruses continuously and naturally evolve. To track coronavirus variants, we need to think like Darwin.

16 Mar 2022

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Researchers estimate the impact of COVID-19 booster doses on infection in a vaccinated population of young adults during Omicron-dominant period.

16 Mar 2022

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

Researchers assessed the placental anti-oxidant response in the third trimester of pregnancy against SARS-CoV-2 infections.

16 Mar 2022

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Researchers evaluated COVID-19 monoclonal antibody treatment in pregnant and postpartum women.

16 Mar 2022

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Researchers identified curcumin derivatives as potential inhibitors of SARS-CoV-2 enzymes.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

Estimating SARS-CoV-2 breakthrough infection numbers in the US

A new study estimated the number of symptomatic COVID-19 breakthrough infections in vaccinated individuals in the US.

16 Mar 2022

Convalescent antibodies do not enhance SARS-CoV-2 infection

Researchers investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 infection.

16 Mar 2022

Roche launched world's first COVID-19 PCR test two years ago

In the two years since it launched the world's first commercially available COVID-19 PCR test, Roche Diagnostics UK and Ireland has distributed ten million tests from its base in West Sussex.

From Roche Sequencing and Life Science 16 Mar 2022

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Since the very beginning of the pandemic, there has been concern about the emergence of Guillain-Barré syndrome, a rare disorder where the body's immune system damages nerves. In some cases, nerve damage causes muscle weakness and paralysis.

16 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

SARS CoV 2 News and Research

Post-COVID condition largely due to SARS-CoV 2 infection, in addition to the indirect pandemic effects

Tracking the mutating coronavirus variants

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Novel targets to inhibit SARS-CoV-2 variants

Estimating SARS-CoV-2 breakthrough infection numbers in the US

Convalescent antibodies do not enhance SARS-CoV-2 infection

Roche launched world's first COVID-19 PCR test two years ago

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Can cardiac biomarkers determine COVID-19 prognosis?

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Serious COVID-19 linked to higher risk of long-term adverse mental health effects

How capable are children to self-swab for SARS-CoV-2?

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News